Page last updated: 2024-08-24

celgosivir and Fever

celgosivir has been researched along with Fever in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, WK; Cherng, BP; Cheung, YB; Chow, A; Chua, LT; Chung, JS; Connolly, J; Hibberd, ML; Hou, Y; Howe, S; Leo, YS; Low, JG; Lye, DC; Ng, LC; Ooi, EE; Rathore, APS; Sung, C; Tambayah, PA; Tan, BH; Tan, KH; Toh, L; Vasudevan, SG; Watanabe, S; Wei, Y; Wijaya, L1

Trials

1 trial(s) available for celgosivir and Fever

ArticleYear
Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial.
    The Lancet. Infectious diseases, 2014, Volume: 14, Issue:8

    Topics: Adult; Aged; Antiviral Agents; Dengue; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Fever; Humans; Indolizines; Male; Middle Aged; Placebos; Singapore; Treatment Outcome; Viral Load; Young Adult

2014